GGPeps timeline
Every GGPeps batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| GGPE-2606-E8495 | CJC-1295 (no DAC) | 02 Jun 2026 | 2026-Q3 | 12 | 98.07 | 0.86 | 98.38 | +0.31 | |
| GGPE-2605-B9821 | BPC-157 | 21 May 2026 | 2026-Q2 | 3 | 98.76 | 1.06 | 98.79 | +0.03 | |
| GGPE-2605-J2051 | TB-500 | 09 May 2026 | 2026-Q2 | 11 | 99.34 | 1.20 | 99.58 | +0.24 | |
| GGPE-2605-U1620 | GHRP-6 | 04 May 2026 | 2026-Q2 | 2 | 98.34 | 0.83 | 98.72 | +0.38 | |
| GGPE-2604-X1414 | Retatrutide | 30 Apr 2026 | 2026-Q2 | 3 | 97.20 | 2.16 | 98.15 | +0.95 | |
| GGPE-2604-K8140 | IGF-1 LR3 | 27 Apr 2026 | 2026-Q2 | 9 | 98.11 | 1.01 | 98.57 | +0.46 | |
| GGPE-2604-H8313 | Tirzepatide | 22 Apr 2026 | 2026-Q2 | 14 | 99.27 | 1.48 | 99.85 | +0.58 | |
| GGPE-2604-L9412 | Semaglutide | 20 Apr 2026 | 2026-Q2 | 4 | 98.80 | 0.91 | 99.26 | +0.46 | |
| GGPE-2604-U8733 | Retatrutide | 16 Apr 2026 | 2026-Q2 | 4 | 98.35 | 1.85 | 98.47 | +0.12 | |
| GGPE-2603-W8751 | Semaglutide | 30 Mar 2026 | 2026-Q2 | 6 | 99.79 | 1.78 | 99.54 | -0.25 | |
| GGPE-2603-R9581 | Cagrilintide | 27 Mar 2026 | 2026-Q2 | 2 | 97.71 | 0.49 | 98.33 | +0.62 | |
| GGPE-2603-P8735 | Melanotan II | 27 Mar 2026 | 2026-Q3 | 8 | 99.51 | 1.54 | 99.74 | +0.23 | |
| GGPE-2603-J9708 | Selank | 15 Mar 2026 | 2026-Q3 | 8 | 98.96 | 1.19 | 99.42 | +0.46 | |
| GGPE-2603-M1446 | Retatrutide | 04 Mar 2026 | 2026-Q2 | 7 | 97.79 | 1.42 | 98.26 | +0.47 | |
| GGPE-2602-G2056 | Selank | 22 Feb 2026 | 2026-Q3 | 9 | 98.50 | 1.41 | 99.26 | +0.76 | |
| GGPE-2602-E8672 | BPC-157 | 20 Feb 2026 | 2026-Q2 | 4 | 98.85 | 0.64 | 99.56 | +0.71 | |
| GGPE-2602-W9566 | ARA-290 | 18 Feb 2026 | 2026-Q1 | 1 | 98.86 | n<2 | 99.20 | +0.34 | |
| GGPE-2602-Y8213 | Semax | 15 Feb 2026 | 2026-Q2 | 4 | 99.09 | 0.22 | 99.67 | +0.58 | |
| GGPE-2602-N9882 | BPC-157 | 15 Feb 2026 | 2026-Q2 | 6 | 98.92 | 0.89 | 99.25 | +0.33 | |
| GGPE-2601-B9932 | TB-500 | 20 Jan 2026 | 2026-Q2 | 7 | 99.54 | 0.77 | 99.90 | +0.36 | |
| GGPE-2601-C2423 | Retatrutide | 02 Jan 2026 | 2026-Q2 | 14 | 98.07 | 1.49 | 98.13 | +0.06 | |
| GGPE-2601-J1391 | Selank | 01 Jan 2026 | 2026-Q2 | 6 | 99.89 | 0.56 | 99.90 | +0.01 | |
| GGPE-2512-A1206 | N-Acetyl Semax Amide | 24 Dec 2025 | 2026-Q2 | 4 | 98.71 | 0.72 | 99.00 | +0.29 | |
| GGPE-2512-M9695 | 5-Amino-1MQ | 23 Dec 2025 | 2026-Q2 | 2 | 99.21 | 0.01 | 99.50 | +0.29 | |
| GGPE-2512-Y8309 | Semax | 21 Dec 2025 | 2026-Q2 | 2 | 99.37 | 1.07 | 99.64 | +0.27 | |
| GGPE-2512-N1746 | BPC-157 | 15 Dec 2025 | 2026-Q1 | 9 | 99.43 | 1.04 | 99.78 | +0.35 | |
| GGPE-2512-G2285 | BPC-157 | 12 Dec 2025 | 2026-Q2 | 6 | 98.32 | 0.87 | 98.54 | +0.22 | |
| GGPE-2512-D9394 | Retatrutide | 09 Dec 2025 | 2026-Q2 | 8 | 98.50 | 0.59 | 98.55 | +0.05 | |
| GGPE-2512-Y9921 | Survodutide | 04 Dec 2025 | 2026-Q2 | 5 | 97.74 | 0.53 | 98.29 | +0.55 | |
| GGPE-2511-R8569 | SLU-PP-332 | 30 Nov 2025 | 2026-Q2 | 12 | 98.65 | 0.94 | 99.00 | +0.35 | |
| GGPE-2511-F8277 | ARA-290 | 29 Nov 2025 | 2025-Q4 | 10 | 99.04 | 1.45 | 98.90 | -0.14 | |
| GGPE-2511-X8435 | Semax | 25 Nov 2025 | 2026-Q1 | 12 | 98.28 | 1.18 | 98.52 | +0.24 | |
| GGPE-2511-Y1573 | Desmopressin | 24 Nov 2025 | 2025-Q4 | 4 | 99.41 | 1.04 | 99.71 | +0.30 | |
| GGPE-2511-K8830 | KPV | 22 Nov 2025 | 2026-Q2 | 10 | 98.61 | 1.31 | 98.71 | +0.10 | |
| GGPE-2511-W9618 | Retatrutide | 20 Nov 2025 | 2026-Q1 | 13 | 97.56 | 2.68 | 97.62 | +0.06 | |
| GGPE-2511-X1688 | Retatrutide | 18 Nov 2025 | 2026-Q2 | 4 | 98.42 | 2.17 | 98.83 | +0.41 | |
| GGPE-2511-S9531 | BPC-157 | 04 Nov 2025 | 2026-Q2 | 2 | 98.53 | 0.30 | 98.92 | +0.39 | |
| GGPE-2510-V1048 | Liraglutide | 31 Oct 2025 | 2026-Q1 | 1 | 98.32 | n<2 | 99.10 | +0.78 | |
| GGPE-2510-C9080 | Semax | 28 Oct 2025 | 2025-Q4 | 1 | 98.89 | n<2 | 99.58 | +0.69 | |
| GGPE-2510-R9180 | Retatrutide | 26 Oct 2025 | 2026-Q1 | 14 | 99.39 | 1.30 | 99.54 | +0.15 | |
| GGPE-2510-H1237 | Enclomiphene citrate | 19 Oct 2025 | 2025-Q4 | 7 | 99.93 | 0.39 | 99.90 | -0.03 | |
| GGPE-2510-C9973 | Liraglutide | 16 Oct 2025 | 2026-Q1 | 5 | 99.08 | 1.69 | 99.06 | -0.02 | |
| GGPE-2510-C1982 | Thymulin | 04 Oct 2025 | 2026-Q1 | 4 | 98.72 | 0.71 | 99.36 | +0.64 | |
| GGPE-2510-L9923 | Tirzepatide | 02 Oct 2025 | 2026-Q1 | 5 | 98.05 | 1.49 | 99.21 | +1.16 | SHARED BULK |
| GGPE-2510-T1661 | CJC-1295 with DAC | 01 Oct 2025 | 2026-Q1 | 12 | 98.01 | 1.73 | 98.57 | +0.56 | |
| GGPE-2509-T2530 | MK-677 (Ibutamoren mesylate) | 19 Sep 2025 | 2026-Q1 | 11 | 99.48 | 0.91 | 99.64 | +0.16 | |
| GGPE-2509-H8939 | Melanotan II | 18 Sep 2025 | 2026-Q1 | 8 | 98.54 | 1.19 | 99.17 | +0.63 | |
| GGPE-2509-N7954 | BPC-157 | 04 Sep 2025 | 2025-Q4 | 6 | 98.90 | 0.88 | 98.50 | -0.40 | SHARED BULK |
| GGPE-2508-U8736 | Sermorelin | 30 Aug 2025 | 2025-Q4 | 4 | 99.17 | 0.23 | 99.90 | +0.73 | |
| GGPE-2508-E9990 | Ipamorelin | 19 Aug 2025 | 2026-Q1 | 6 | 99.74 | 0.40 | 99.90 | +0.16 | |
| GGPE-2508-J1903 | MOTS-c | 13 Aug 2025 | 2025-Q4 | 13 | 98.74 | 1.04 | 98.79 | +0.05 | |
| GGPE-2508-E8992 | Retatrutide | 12 Aug 2025 | 2025-Q3 | 10 | 97.97 | 1.40 | 98.08 | +0.11 | |
| GGPE-2507-Y1706 | Cagrilintide | 29 Jul 2025 | 2025-Q4 | 8 | 98.16 | 1.68 | 98.50 | +0.34 | |
| GGPE-2507-S1153 | MK-677 (Ibutamoren mesylate) | 27 Jul 2025 | 2025-Q3 | 7 | 99.93 | 0.16 | 99.62 | -0.31 | |
| GGPE-2507-D8658 | CJC-1295 (no DAC) | 09 Jul 2025 | 2025-Q4 | 7 | 98.78 | 1.60 | 98.92 | +0.14 | |
| GGPE-2506-T9249 | MGF | 27 Jun 2025 | 2025-Q4 | 1 | 98.34 | n<2 | 98.88 | +0.54 | |
| GGPE-2505-W9629 | Liraglutide | 25 May 2025 | 2025-Q4 | 14 | 98.55 | 2.00 | 99.13 | +0.58 | |
| GGPE-2502-H2314 | MK-677 (Ibutamoren mesylate) | 23 Feb 2025 | 2025-Q1 | 4 | 98.36 | 0.52 | 98.50 | +0.14 | |
| GGPE-2502-J8885 | Tirzepatide | 22 Feb 2025 | 2025-Q3 | 11 | 97.86 | 1.76 | 98.53 | +0.67 | |
| GGPE-2502-U2458 | BPC-157 | 15 Feb 2025 | 2025-Q3 | 14 | 99.56 | 0.87 | 100.00 | +0.44 | |
| GGPE-2502-S9820 | BPC-157 | 10 Feb 2025 | 2025-Q1 | 5 | 98.81 | 0.79 | 99.50 | +0.69 | |
| GGPE-2502-W9548 | NAD+ | 09 Feb 2025 | 2025-Q2 | 3 | 98.56 | 0.49 | 99.27 | +0.71 | |
| GGPE-2501-B9507 | TB-500 | 19 Jan 2025 | 2025-Q1 | 1 | 98.74 | n<2 | 99.40 | +0.66 | |
| GGPE-2501-W9136 | Semaglutide | 08 Jan 2025 | 2025-Q1 | 9 | 98.47 | 1.63 | 98.75 | +0.28 | |
| GGPE-2501-J1308 | L-Glutathione (reduced) | 05 Jan 2025 | 2025-Q1 | 2 | 98.76 | 0.61 | 99.50 | +0.74 | |
| GGPE-2412-M1040 | Tirzepatide | 08 Dec 2024 | 2025-Q2 | 6 | 98.00 | 0.49 | 98.41 | +0.41 | |
| GGPE-2411-V1398 | BPC-157 | 21 Nov 2024 | 2025-Q2 | 6 | 98.97 | 0.67 | 98.96 | -0.01 | |
| GGPE-2411-R7895 | Retatrutide | 19 Nov 2024 | 2024-Q4 | 6 | 99.30 | 0.81 | 100.00 | +0.70 | |
| GGPE-2411-R9751 | KPV | 06 Nov 2024 | 2025-Q2 | 14 | 98.63 | 2.22 | 99.06 | +0.43 | |
| GGPE-2411-B9190 | Ipamorelin | 06 Nov 2024 | 2025-Q2 | 6 | 99.05 | 0.70 | 99.66 | +0.61 | |
| GGPE-2410-S9487 | Enclomiphene citrate | 30 Oct 2024 | 2025-Q1 | 7 | 98.30 | 0.72 | 98.75 | +0.45 | |
| GGPE-2410-L1879 | Semaglutide | 22 Oct 2024 | 2024-Q4 | 5 | 98.53 | 0.55 | 98.66 | +0.13 | |
| GGPE-2410-U9081 | Cagrilintide | 11 Oct 2024 | 2024-Q4 | 3 | 98.59 | 0.70 | 99.00 | +0.41 | |
| GGPE-2410-U1370 | Hexarelin | 05 Oct 2024 | 2024-Q4 | 1 | 98.90 | n<2 | 99.33 | +0.43 | |
| GGPE-2409-C8719 | Sermorelin | 11 Sep 2024 | 2024-Q4 | 11 | 98.43 | 1.21 | 98.26 | -0.17 | |
| GGPE-2408-G9786 | CJC-1295 (no DAC) | 26 Aug 2024 | 2025-Q1 | 1 | 98.27 | n<2 | 98.99 | +0.72 | |
| GGPE-2408-Y9789 | Semaglutide | 20 Aug 2024 | 2024-Q3 | 7 | 97.75 | 0.34 | 98.51 | +0.76 | |
| GGPE-2406-E1965 | BPC-157 | 26 Jun 2024 | 2024-Q3 | 10 | 99.93 | 0.76 | 99.90 | -0.03 | |
| GGPE-2406-F8997 | GHRP-2 | 24 Jun 2024 | 2024-Q4 | 1 | 99.04 | n<2 | 99.78 | +0.74 | |
| GGPE-2405-A1540 | NAD+ | 08 May 2024 | 2024-Q4 | 7 | 97.92 | 0.71 | 98.17 | +0.25 | |
| GGPE-2405-P2227 | Semaglutide | 06 May 2024 | 2024-Q3 | 17 | 98.05 | 1.36 | 98.30 | +0.25 | |
| GGPE-2404-D2105 | Semaglutide | 22 Apr 2024 | 2024-Q2 | 2 | 98.55 | 0.63 | 98.61 | +0.06 | |
| GGPE-2404-K1160 | Retatrutide | 04 Apr 2024 | 2024-Q3 | 9 | 98.02 | 1.75 | 98.61 | +0.59 | |
| GGPE-2403-N2129 | Humanin (HNG) | 24 Mar 2024 | 2024-Q2 | 7 | 99.22 | 0.97 | 99.60 | +0.38 | |
| GGPE-2312-B8962 | Hexarelin | 05 Dec 2023 | 2024-Q2 | 1 | 99.53 | n<2 | 99.04 | -0.49 |